What are Harmony Biosciences Holdings, Inc.'s profit margins?

Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.

Where do Harmony Biosciences Holdings, Inc.'s ratios come from?

Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Harmony Biosciences Holdings, Inc. HRMY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	77.2%-0.9pp	78.1%-1.1pp	79.2%-1.8pp	80.9%-0.9pp
Operating margin	24%-2.7pp	26.7%-6.3pp	33%+5.5pp	27.4%-1.2pp
Net margin	18.3%-2.1pp	20.4%-1.8pp	22.1%-19.3pp	41.4%+30.1pp
EBITDA margin	26.8%-3.3pp	30.1%-7.1pp	37.2%+4.4pp	32.8%-2.0pp
Free cash flow margin	40.1%+9.5pp	30.6%—	——	33%+0.8pp
Returns
Return on equity	20.8%-5.1pp	25.8%-3.8pp	29.6%-32.0pp	61.6%+37.2pp
Return on assets	14%-2.1pp	16.1%-1.3pp	17.4%-15.4pp	32.8%+24.7pp
Return on invested capital	45.6%+6.4pp	39.2%-1.3pp	40.5%-7.5pp	48%-28.8pp
Efficiency
Asset turnover	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×+0.1×
Inventory turnover	31.6×+6.6×	25×-0.1×	25.1×+6.0×	19.1×+5.7×
Liquidity
Current ratio	3.6×+0.3×	3.3×+0.6×	2.8×-2.3×	5.1×-0.2×
Quick ratio	3.6×+0.3×	3.3×+0.5×	2.7×-2.3×	5×-0.2×
Cash ratio	3×+0.4×	2.6×+0.7×	1.9×-1.2×	3.1×-1.3×
Leverage
Debt-to-equity	0.2×-0.1×	0.3×-0.1×	0.4×-0.1×	0.5×-0.6×
Debt-to-assets	0.1×0.0×	0.2×-0.1×	0.2×0.0×	0.3×-0.2×
Net debt / EBITDA	-2.5×-1.2×	-1.3×-0.7×	-0.5×-0.2×	-0.3×0.0×
Interest coverage	14.2×+3.3×	10.9×+2.8×	8.1×+1.7×	6.4×+2.8×
Per Share
Book value per share	$14.86+30.5%	$11.39+47.3%	$7.74+17.3%	$6.59+109%
Valuation
Market capitalization	$2.16B+9.8%	$1.96B+4.2%	$1.88B-42.5%	$3.28B+30.5%
Enterprise value	$1.57B-7.0%	$1.69B-4.4%	$1.77B-45.2%	$3.23B+30.5%
Price / earnings	13.6×+0.1×	13.5×-1.1×	14.6×-3.4×	18.1×-54.5×
Price / sales	2.5×-0.3×	2.7×-0.5×	3.2×-4.2×	7.5×-0.7×
Price / book	2.5×-0.5×	3×-1.1×	4×-4.1×	8.1×-5.3×
EV / EBITDA	6.8×-1.1×	7.9×-0.3×	8.2×-14.3×	22.5×-0.8×
EV / sales	1.8×-0.6×	2.4×-0.7×	3×-4.3×	7.4×-0.7×
Free cash flow yield	16.1%+5.0pp	11.1%—	——	4.4%+0.5pp
Earnings yield	7.4%-0.1pp	7.4%+0.6pp	6.8%+1.3pp	5.5%+4.2pp
PEG ratio	1.5×+0.5×	1×—	——	0×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?: Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.
Where do Harmony Biosciences Holdings, Inc.'s ratios come from?: Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.